Skip to main content

Advertisement

Log in

Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence Base

  • Review Article
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Non-alcoholic fatty liver disease and non-alcoholic steato-hepatitis are common in patients undergoing bariatric surgery. Non-alcoholic steato-hepatitis can progress to cirrhosis of the liver and hepatocellular carcinoma. Non-invasive methods of diagnosing non-alcoholic steato-hepatitis are not as accurate as liver biopsy, and bariatric surgery presents a unique opportunity to carry out a simultaneous liver biopsy. Routine liver biopsy can help early and accurate diagnosis of obesity-associated liver conditions. This has led some surgeons to argue for routine liver biopsy at the time of bariatric surgery. However, most bariatric surgeons remain unconvinced and liver biopsy is currently not routine practice with bariatric surgery. This review examines published scientific literature to ascertain the usefulness of routine liver biopsy at the time of bariatric surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

NAFLD:

Non-alcoholic fatty liver disease

NASH:

Non-alcoholic steato-hepatitis

HCC:

Hepato-cellular carcinoma

References

  1. Subichin M, Clanton J, Makuszewski M, et al. Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgery. Surg Obes Relat Dis. 2015;11(1):137–41.

    Article  PubMed  Google Scholar 

  2. Reha JL, Lee S, Hofmann LJ. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience. Am Surg. 2014;80(6):595–9.

    PubMed  Google Scholar 

  3. Losekann A, Weston AC, Carli LA, et al. Nonalcoholic fatty liver disease in severe obese patients, subjected to bariatric surgery. Arq Gastroenterol. 2013;50(4):285–9.

    Article  PubMed  Google Scholar 

  4. Praveenraj P, Gomes RM, Kumar S, et al. Prevalence and predictors of non-alcoholic fatty liver disease in morbidly obese South Indian patients undergoing bariatric surgery. Obes Surg. 2015.

  5. Seki Y, Kakizaki S, Horiguchi N, et al. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery. J Gastroenterol. 2015.

  6. Teixeira AR, Bellodi-Privato M, Carvalheira JB, et al. The incapacity of the surgeon to identify NASH in bariatric surgery makes biopsy mandatory. Obes Surg. 2009;19(12):1678–84.

    Article  PubMed  Google Scholar 

  7. Shalhub S, Parsee A, Gallagher SF, et al. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obes Surg. 2004;14(1):54–9.

    Article  PubMed  Google Scholar 

  8. Dolce CJ, Russo M, Keller JE, et al. Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery. Surg Obes Relat Dis. 2009;5(3):323–8.

    Article  PubMed  Google Scholar 

  9. Verna EC. Liver biopsy at the time of bariatric surgery: a benefit for patients and the medical community. Semin Liver Dis. 2014;34(1):1–6.

    Article  PubMed  Google Scholar 

  10. Dallal RM, Samuel G, Lord JL, et al. Hemobilia: a rare complication after routine liver biopsy during gastric bypass. Surg Obes Relat Dis. 2007;3(1):91–3.

    Article  PubMed  Google Scholar 

  11. Quezada N, León F, Martínez J, et al. Emergency right hepatectomy after laparoscopic tru-cut liver biopsy. Int J Surg Case Rep. 2015;8C:42–4.

    Article  PubMed  Google Scholar 

  12. Denzer U, Arnoldy A, Kanzler S, et al. Prospective randomized comparison of minilaparoscopy and percutaneous liver biopsy: diagnosis of cirrhosis and complications. J Clin Gastroenterol. 2007;41(1):103–10.

    Article  PubMed  Google Scholar 

  13. Bellentani S, Scaglioni F, Marino M, et al. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010;28(1):155–61.

    Article  PubMed  Google Scholar 

  14. Sasaki A, Nitta H, Otsuka K, et al. Bariatric surgery and non-alcoholic fatty liver disease: current and potential future treatments. Front Endocrinol (Lausanne). 2014;5:164.

    Google Scholar 

  15. Hashimoto E, Tokushige K. Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol. 2011;46 Suppl 1:63–9.

    Article  PubMed  Google Scholar 

  16. Sanyal AJ, Brunt EM, Kleiner DE, et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011;54(1):344–53.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hyysalo J, Männistö VT, Zhou Y, et al. A population-based study on the prevalence of NASH using scores validated against liver histology. J Hepatol. 2014;60(4):839–46.

    Article  PubMed  Google Scholar 

  18. Hu KC, Wang HY, Liu SC, et al. Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease. World J Gastroenterol. 2014;20(24):7718–29.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol. 2014;5(3):211–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  20. Campos GM, Bambha K, Vittinghoff E, et al. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients. Hepatology. 2008;47(6):1916–23.

    Article  PubMed  Google Scholar 

  21. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol. 2012;107(6):811–26.

    Article  PubMed  Google Scholar 

  22. Jan A, Narwaria M, Mahawar KK. A systematic review of bariatric surgery in patients with liver cirrhosis. Obes Surg. 2015;25(8):1518–26.

    Article  PubMed  Google Scholar 

  23. Helmreich-Becker I, Schirmacher P, Denzer U, et al. Minilaparoscopy in the diagnosis of cirrhosis: superiority in patients with Child-Pugh A and macronodular disease. Endoscopy. 2003;35(1):55–60.

    Article  PubMed  CAS  Google Scholar 

  24. Jalan R, Harrison DJ, Dillon JF, et al. Laparoscopy and histology in the diagnosis of chronic liver disease. QJM. 1995;88(8):559–64.

    PubMed  CAS  Google Scholar 

  25. Crantock LR, Dillon JF, Hayes PC. Diagnostic laparoscopy and liver disease: experience of 200 cases. Aust N Z J Med. 1994;24(3):258–62.

    Article  PubMed  CAS  Google Scholar 

  26. Poniachik J, Bernstein DE, Reddy KR, et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc. 1996;43(6):568–71.

    Article  PubMed  CAS  Google Scholar 

  27. Pagliaro L, Rinaldi F, Craxì A, et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci. 1983;28(1):39–43.

    Article  PubMed  CAS  Google Scholar 

  28. Weickert U, Siegel E, Schilling D, et al. The diagnosis of liver cirrhosis: a comparative evaluation of standard laparoscopy, mini-laparoscopy and histology. Z Gastroenterol. 2005;43(1):17–21.

    Article  PubMed  CAS  Google Scholar 

  29. Cazzo E, Jimenez LS, Pareja JC, et al. Effect of Roux-en-y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study. Obes Surg. 2014.

  30. Furuya Jr CK, de Oliveira CP, de Mello ES, et al. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol. 2007;22(4):510–4.

    Article  PubMed  CAS  Google Scholar 

  31. Weiner RA. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Dig Dis. 2010;28(1):274–9.

    Article  PubMed  CAS  Google Scholar 

  32. de Almeida SR, Rocha PR, Sanches MD, et al. Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity. Obes Surg. 2006;16(3):270–8.

    Article  PubMed  Google Scholar 

  33. Lassailly G, Caiazzo R, Buob D, et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology. 2015;149(2):379–88.

    Article  PubMed  Google Scholar 

  34. Praveen Raj P, Gomes RM, Kumar S, et al. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trial. Surg Obes Relat Dis. 2015. doi:10.1016/j.soard.2015.02.006.

    PubMed  Google Scholar 

  35. Taitano AA, Markow M, Finan JE, et al. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J Gastrointest Surg. 2015;19(3):429–36.

    Article  PubMed  Google Scholar 

  36. Mummadi RR, Kasturi KS, Chennareddygari S, et al. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008;6(12):1396–402.

    Article  PubMed  Google Scholar 

  37. Estep JM, Birerdinc A, Younossi Z. Non-invasive diagnostic tests for non-alcoholic fatty liver disease. Curr Mol Med. 2010;10(2):166–72.

    Article  PubMed  CAS  Google Scholar 

  38. Haydon GH, Hayes PC. Diagnostic laparoscopy by physicians: we should do it. QJM. 1997;90(4):297–304.

    Article  PubMed  CAS  Google Scholar 

  39. Ramos-De la Medina A, Remes-Troche JM, Roesch-Dietlen FB, et al. Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified? J Gastrointest Surg. 2008;12(12):2097–102.

    Article  PubMed  Google Scholar 

  40. Zuegel NP, Hehl JA, Auerbach-Heber K, et al. Value of liver biopsy combined with cholecystectomy. Hepatogastroenterology. 1999;46(30):3095–8.

    PubMed  CAS  Google Scholar 

  41. Chavez-Tapia NC, Tellez-Avila FI, Barrientos-Gutierrez T, et al. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev. 2010;1, CD007340.

    PubMed  Google Scholar 

  42. Younossi ZM, Reyes MJ, Mishra A, et al. Systematic review with meta-analysis: non-alcoholic steatohepatitis—a case for personalised treatment based on pathogenic targets. Aliment Pharmacol Ther. 2014;39(1):3–14.

    Article  PubMed  CAS  Google Scholar 

  43. Nascimbeni F, Pais R, Bellentani S, et al. From NAFLD in clinical practice to answers from guidelines. J Hepatol. 2013;59(4):859–71.

    Article  PubMed  Google Scholar 

  44. Ratziu V, Bellentani S, Cortez-Pinto H, et al. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010;53(2):372–84.

    Article  PubMed  Google Scholar 

  45. British Society of Gastroenterology: guidelines on the use of liver biopsy in clinical practice. http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/liver/liver_biopsy.pdf Accessed 12 Apr 2015.

  46. British Society of Gastroenterology: chronic management of NASH/NAFLD. http://www.bsg.org.uk/images/Commissioning_report/BSG_NASH_and_Non-Alcoholic_Fatty_Liver_Disease.pdf Accessed 12 Apr 2015.

Download references

Author Contribution

KM conceived the idea for the topic. KM and CP independently collected information and analysed it. All authors participated in departmental discussion on the topic and manuscript writing. All authors have seen the final version and approve of it.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kamal K. Mahawar.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Statement of Human and Animal Rights

Not applicable

Statement of Informed Consent

Not applicable

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mahawar, K.K., Parmar, C., Graham, Y. et al. Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence Base. OBES SURG 26, 177–181 (2016). https://doi.org/10.1007/s11695-015-1916-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-015-1916-z

Keywords

Navigation